Flibanserin, sold under the brand name Fliban, is a medication primarily used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It works by affecting neurotransmitters in the brain, particularly serotonin and dopamine, which are involved in regulating sexual desire.

When comparing the effectiveness of 100mg and 50mg doses of Fliban, the level of sexual arousal or stimulation can influence the outcomes, but not necessarily in the same way as with medications used to treat erectile dysfunction in men. Here's how the level of sexual arousal or stimulation may impact the comparative effectiveness of different doses of Fliban:

1. 
   

   100mg Dose:

   
   
   • A higher dose of Fliban 100 mg may be more effective in increasing sexual desire and arousal in women who have lower baseline levels of sexual desire or who experience more severe symptoms of HSDD.
   
   
   • Women taking the 100mg dose of Fliban may experience greater improvements in sexual desire and satisfaction, especially if they have not responded adequately to lower doses.
   
   


2. 
   

   50mg Dose:

   
   
   • A lower dose of Fliban (50mg) may be sufficient for some women with milder symptoms of HSDD or those who have a moderate level of sexual arousal and desire.
   
   
   • Women who are more sensitive to medications or who experience side effects with higher doses may find that the 50mg dose is effective with fewer adverse effects.
   
   

The effectiveness of both doses of Fliban may also depend on individual factors such as hormonal balance, psychological factors, relationship dynamics, and overall health. It's essential for women with HSDD to work closely with their healthcare providers to determine the most appropriate dose of Fliban based on their specific needs and response to treatment.

It's important to note that Fliban is not intended for use as a "quick fix" for low sexual desire and arousal; rather, it is part of a comprehensive treatment approach that may include counseling, lifestyle modifications, and addressing underlying medical or psychological issues contributing to HSDD. Additionally, Fliban is not suitable for everyone, and its use should be carefully considered in consultation with a healthcare professional.